Loring Wolcott & Coolidge Fiduciary Advisors’s Aemetis AMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,961
Closed -$9.61K 525
2025
Q1
$9.61K Buy
+6,961
New +$14.9K ﹤0.01% 485

Other funds holding AMTX

Loring Wolcott & Coolidge Fiduciary Advisors's AMTX Position: Q2 2025 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Aemetis (AMTX) in Q2 2025, closing a stake of 6,961 shares — an estimated $9.61K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in AMTX in Q1 2025 and held it in 1 quarter. The position peaked at $9.61K in Q1 2025. 71 funds tracked by Wall St. Rank hold AMTX as of Q2 2025.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Aemetis position as of Q2 2025 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 6,961 Aemetis shares in Q2 2025, an estimated $9.61K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Aemetis in Q1 2025 and held it in 1 quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Aemetis position peaked at $9.61K in Q1 2025.
  • 71 funds tracked by Wall St. Rank held Aemetis as of Q2 2025.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2025, filed 30 Jul 2025.